Priscilla Turelli
Lausanne, VD 1015, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Cancer cells subvert the primate-specific KRAB zinc finger protein ZNF93 to control APOBEC3B.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 19, 2025
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys.
Journal: The Journal of infection
Published: July 31, 2023
A Cluster of Evolutionarily Recent KRAB Zinc Finger Proteins Protects Cancer Cells from Replicative Stress-Induced Inflammation.
Journal: Cancer research
Published: April 24, 2023
Genetic features and genomic targets of human KRAB-zinc finger proteins.
Journal: Genome research
Published: January 19, 2023
Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range.
Journal: PLoS pathogens
Published: October 27, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
Journal: The Lancet regional health. Europe
Published: August 22, 2022
De novo design of protein interactions with learned surface fingerprints.
Journal: Nature
Published: June 16, 2022
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma.
Journal: Life science alliance
Published: October 22, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concern.
Journal: Cell reports
Published: April 28, 2021
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.
Journal: Science translational medicine
Published: April 05, 2021
Last Updated: 09/26/2026